...
首页> 外文期刊>Human Pathology >Primary mucinous adenocarcinoma of the female urethra: a contemporary clinicopathologic analysis
【24h】

Primary mucinous adenocarcinoma of the female urethra: a contemporary clinicopathologic analysis

机译:女性尿道原发性黏液腺癌:当代临床病理分析

获取原文
获取原文并翻译 | 示例
           

摘要

Primary mucinous adenocarcinoma of the female urethra is very rare and may lead to both diagnostic and therapeutic challenges. Although primary mucinous adenocarcinoma of the prostate and prostatic urethra has been well characterized in men, this is the largest clinicopathologic study to date of primary mucinous adenocarcinoma of the female urethra. A search was made through the files of 2 major academic institutions for cases of confirmed primary mucinous adenocarcinoma arising from the female urethra. Tumors arising from adjacent organs were excluded both clinically and pathologically in all cases. Five cases were identified. The mean patient age was 67 years (range, 54-74 years). All patients presented with a polypoid/papillary mass arising from the urethra. Pathologic stages were as follows: pT4 3 (60%) of 5 cases; pT3 1 (20%) of 5 cases, and pT2 1 (20%) of 5 cases. Immunohistochemical stains for GATA3, p63, CK7, CK20, CDX2, ER, PAX8, and P-catenin were performed on all cases. Immunohistochemical stains were positive in the tumor cells for CDX2 in 4/5 (80%) cases; focally positive for CK20 in 4/5 (80%) cases; focally positive for CK7 in 4/5 cases (80%); and negative for p63, GATA3, ER, PAX8 and /3-catenin in all cases. In the 4 patients with available follow-up data, mean follow-up was 25 months (range, 4-54 months). It is critical for pathologists to be aware of this entity in light of potential diagnostic pitfalls and therapeutic implications. (C) 2015 Elsevier Inc. All rights reserved.
机译:女性尿道的原发性黏液腺癌非常罕见,可能导致诊断和治疗方面的挑战。尽管在男性中前列腺和前列腺尿道的原发性黏液腺癌已被很好地表征,但这是迄今为止女性尿道的原发性黏液腺癌中最大的临床病理研究。通过两个主要学术机构的档案进行了搜索,以确认女性尿道引起的原发性粘液性腺癌的确诊病例。在所有情况下,临床和病理均排除了邻近器官引起的肿瘤。确定了五例。患者平均年龄为67岁(范围54-74岁)。所有患者均出现尿道息肉样/乳头状肿块。病理分期如下:5例中pT4 3(60%); 5例中pT3 1(20%),5例中pT2 1(20%)。对所有病例均进行了GATA3,p63,CK7,CK20,CDX2,ER,PAX8和P-catenin的免疫组织化学染色。 4/5(80%)病例的肿瘤细胞中CDX2的免疫组织化学染色阳性。在4/5(80%)病例中CK20呈局部阳性;在4/5例中CK7呈局灶性阳性(80%);在所有情况下对p63,GATA3,ER,PAX8和/ 3-catenin均为阴性。在可获得随访数据的4例患者中,平均随访时间为25个月(范围4-54个月)。对于病理学家而言,根据潜在的诊断缺陷和治疗意义,意识到这一实体至关重要。 (C)2015 Elsevier Inc.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号